Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3 B3GAT1	2.30e-06	35	224	6	GO:0015020
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor	DHFR DHFR2 PYCR1 PYCR2	4.17e-05	18	224	4	GO:0016646
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.55e-04	28	224	4	GO:0001972
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH group of donors	DHFR DHFR2 PYCR1 PYCR2	3.36e-04	30	224	4	GO:0016645
GeneOntologyMolecularFunction	dihydrofolic acid binding	DHFR DHFR2	3.73e-04	3	224	2	GO:0051871
GeneOntologyMolecularFunction	dihydrofolate reductase activity	DHFR DHFR2	3.73e-04	3	224	2	GO:0004146
GeneOntologyMolecularFunction	FFAT motif binding	VAPB MOSPD2	3.73e-04	3	224	2	GO:0033149
GeneOntologyCellularComponent	anchoring junction	ADAM15 MPDZ NPHP4 JAK1 DST PTPRK FMN1 PI4KA AHNAK AMOTL1 PPP1R9B DLG4 FLNB ANK3 PNN DSP ARHGEF5 FRMPD2 ARHGAP17 SRCIN1 LAP3 SLC3A2 AFAP1 FHOD1 DOCK7 PCDH9 CDH9	6.94e-06	976	225	27	GO:0070161
GeneOntologyCellularComponent	cell-cell junction	ADAM15 MPDZ NPHP4 DST PTPRK FMN1 AHNAK AMOTL1 PPP1R9B DLG4 ANK3 PNN DSP FRMPD2 ARHGAP17 FHOD1 PCDH9 CDH9	7.71e-05	591	225	18	GO:0005911
GeneOntologyCellularComponent	basal part of cell	DST PKD1 DLG4 SLC4A9 HJV ANK3 DSP FRMPD2 ABCC5 SLC3A2 SLC9A4 SLC16A3 DOCK7	2.45e-04	378	225	13	GO:0045178
GeneOntologyCellularComponent	basal plasma membrane	DST PKD1 DLG4 SLC4A9 HJV ANK3 DSP FRMPD2 ABCC5 SLC3A2 SLC9A4 SLC16A3	4.81e-04	354	225	12	GO:0009925
GeneOntologyCellularComponent	preribosome, small subunit precursor	RRP1B UTP20 FTSJ3	5.09e-04	15	225	3	GO:0030688
GeneOntologyCellularComponent	cell-cell contact zone	DST AHNAK ANK3 DSP FHOD1 PCDH9	5.38e-04	94	225	6	GO:0044291
MousePheno	abnormal temporal memory	KDM5C ESR2 RYR3 LRP8 KSR1 KLF9 KCTD16 DLG4 UHRF2 KALRN EFNA3 SLC16A3 PCDH9	1.25e-05	239	179	13	MP:0001468
MousePheno	abnormal neurite morphology	VAPB KDM5C ZDHHC8 SLC12A5 DST AFG3L2 DLG4 HERC2 PYCR2 KALRN SRGAP2 SRCIN1 SLC16A3 VPS35 ATM AGRN PCDH9	5.36e-05	442	179	17	MP:0008415
MousePheno	abnormal contextual conditioning behavior	KDM5C ESR2 RYR3 LRP8 KSR1 KLF9 KCTD16 DLG4 UHRF2 KALRN EFNA3	6.67e-05	205	179	11	MP:0001469
MousePheno	abnormal platelet ADP level	LYST DOCK7 HPS5	6.96e-05	7	179	3	MP:0009556
MousePheno	decreased platelet ADP level	LYST DOCK7 HPS5	6.96e-05	7	179	3	MP:0009557
MousePheno	abnormal hair cycle	ESR2 LYST ITPR3 KSR1 MSX2 TBK1	6.98e-05	55	179	6	MP:0000427
Domain	UDPGT	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.95e-06	21	222	5	PF00201
Domain	UDP_glucos_trans	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.95e-06	21	222	5	IPR002213
Domain	UDPGT	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.95e-06	21	222	5	PS00375
Domain	ARM-type_fold	MON2 LYST RYR3 PI4KA NBEAL2 UTP20 ZER1 APOB PPP2R1A MTOR FHOD1 VPS35 IPO13 ATM	5.76e-05	339	222	14	IPR016024
Domain	ST7	ST7L ST7	1.41e-04	2	222	2	PF04184
Domain	DHFR_1	DHFR DHFR2	1.41e-04	2	222	2	PF00186
Domain	DHFR_dom	DHFR DHFR2	1.41e-04	2	222	2	IPR001796
Domain	DHFR_2	DHFR DHFR2	1.41e-04	2	222	2	PS51330
Domain	DHFR-like_dom	DHFR DHFR2	1.41e-04	2	222	2	IPR024072
Domain	DHFR_1	DHFR DHFR2	1.41e-04	2	222	2	PS00075
Domain	ST7	ST7L ST7	1.41e-04	2	222	2	IPR007311
Domain	-	DHFR DHFR2	1.41e-04	2	222	2	3.40.430.10
Domain	DHFR	DHFR DHFR2	1.41e-04	2	222	2	IPR012259
Domain	-	PYCR1 PYCR2	4.19e-04	3	222	2	1.10.3730.10
Domain	Beta-propeller_rpt_TECPR	TECPR2 HERC2	4.19e-04	3	222	2	IPR006624
Domain	TECPR	TECPR2 HERC2	4.19e-04	3	222	2	SM00706
Domain	P5CR_dimer	PYCR1 PYCR2	4.19e-04	3	222	2	PF14748
Domain	P5CR_dimer	PYCR1 PYCR2	4.19e-04	3	222	2	IPR029036
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	AGL GPI UGT1A5 SI UGT1A4 UGT1A1 UGT1A3	3.24e-06	52	174	7	M14171
Pathway	REACTOME_GLUCURONIDATION	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.51e-06	24	174	5	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.18e-05	25	174	5	M17787
Pathway	KEGG_ARGININE_AND_PROLINE_METABOLISM	CKMT2 PYCR1 PYCR2 CKMT1A LAP3 ARG2	5.13e-05	54	174	6	M2551
Pathway	REACTOME_HEME_DEGRADATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.31e-05	20	174	4	MM14721
Pathway	REACTOME_RHO_GTPASE_CYCLE	VAPB IL32 MOSPD2 NCF2 PLEKHG1 DST FGD3 ARAP1 KALRN DSP ARHGEF5 ARHGAP17 CCDC187 CPD SRGAP2 DOCK7	1.45e-04	450	174	16	M27078
Pathway	REACTOME_CDC42_GTPASE_CYCLE	PLEKHG1 FGD3 ARAP1 ARHGEF5 ARHGAP17 SRGAP2 DOCK7	1.61e-04	94	174	7	MM15598
Pathway	REACTOME_ASPIRIN_ADME	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.99e-04	44	174	5	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.22e-04	45	174	5	MM15694
Pathway	WP_GLUCURONIDATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.32e-04	25	174	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.32e-04	25	174	4	M605
Pathway	WP_GLUCURONIDATION	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.71e-04	26	174	4	M39404
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 VAPB MOSPD2 RRP1B PSMC5 TSC1 KIAA0753 ITPR3 PTPN7 MTMR11 GSE1 PTPRK PI4KA AHNAK AFG3L2 PYCR1 PPP1R9B HERC2 PYCR2 PRRC2A ANK3 DSP ST7 RALGAPB CPD SLC3A2 KIAA1671 PPP2R1A PPP3CB HDLBP FTSJ3	4.13e-12	1049	231	31	27880917
Pubmed	Functional proteomics mapping of a human signaling pathway.	MTMR11 DST PKD1 PPP1R9B HERC2 PYCR2 UHRF2 VCPIP1 FLNB ANK3 MTF2 PIR SKI ASH2L PPP2R1A ZNF592 VPS35 TNFAIP3 GGA1 HDLBP	3.48e-09	591	231	20	15231748
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MPDZ ADAR AHNAK AMOTL1 KDM2B PRRC2A VCPIP1 ANK3 PNN DSP RBBP4 ASH2L SLC3A2 KIAA1671 PPP2R1A UBE2O DOCK7 TP53BP1 HDLBP	6.08e-09	549	231	19	38280479
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 LHPP NPHP4 ZDHHC8 LYST ITPR3 PLEKHG1 ZGPAT DST PI4KA NBEAL2 AHNAK SLC35A2 PKD1 ZER1 HERC2 ARAP1 SEMA6C KALRN ARHGAP17 SRGAP2 MSX2 ZNF592 MTOR TNFAIP3 GGA1 AGRN	6.74e-09	1105	231	27	35748872
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	VAPB TSC1 BCL11A SLC12A5 DST PI4KA EHD1 AFG3L2 PPP1R9B DLG4 PYCR2 CORO7 PRRC2A CKMT1A GPI FLNB SELENBP1 ANK3 KALRN DSP SRGAP2 SRCIN1 SLC3A2 MLXIPL PPP2R1A UBE2O AFAP1 VPS35 DOCK7 TMOD1 HDLBP	7.90e-09	1431	231	31	37142655
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PSMC5 TSC1 ADAR ZGPAT DST PI4KA AHNAK EHD1 AFG3L2 PYCR1 UTP20 HERC2 PYCR2 CORO7 GPI FLNB PNN DSP RBBP4 DHX40 SNX33 SLC3A2 PPP2R1A FHOD1 VPS35 KIF18B AGRN TP53BP1 HDLBP FTSJ3	8.38e-09	1353	231	30	29467282
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MON2 VAPB RRP1B MPDZ PSMC5 ITPR3 PTPN7 PTPRK AGL AFG3L2 PYCR1 DLG4 PYCR2 CORO7 PRRC2A QSOX2 VCPIP1 FLNB DHX40 CPD SLC3A2 PPP2R1A UBE2O MTOR VPS35	9.74e-09	974	231	25	28675297
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A5 UGT1A4 UGT1A1 UGT1A3 SUGP1	1.53e-08	13	231	5	25246029
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RRP1B PSMC5 ITPR3 DST AHNAK UTP20 HERC2 PRRC2A FLNB PNN DSP RBBP4 PPP2R1A UBE2O MTOR DOCK7 ATM TP53BP1 HDLBP FTSJ3	1.84e-08	653	231	20	22586326
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MON2 VAPB TRAF3IP1 RRP1B PSMC5 DPP8 NPHP4 KSR1 AHNAK AMOTL1 AFG3L2 EIF2B2 CRNN GPI ANK3 SRGAP2 SNX33 KIAA1671 PPP2R1A NPHP3 MTOR TBK1 DOCK7 IPO13 IFT122 KIF18B GGA1 PCDH9 TP53BP1	1.89e-08	1321	231	29	27173435
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	VAPB PSMC5 TSC1 ADAR DST GSE1 AHNAK AFG3L2 PPP1R9B PRRC2A VCPIP1 GPI NEBL PNN DSP SRGAP2 SLC3A2 KIAA1671 UBE2O FHOD1 SUGP1 TP53BP1 HDLBP FTSJ3	1.92e-08	934	231	24	33916271
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 VAPB RRP1B PSMC5 ITPR3 DST AHNAK EHD1 AFG3L2 EIF2B2 PYCR1 RARS2 PYCR2 PRRC2A ALPI FLNB PNN RBBP4 ST7 SLC3A2 ARG2 KIAA1671 PPP2R1A AFAP1 MTOR VPS35 DOCK7 IPO13 TMOD1 ATM	3.36e-08	1440	231	30	30833792
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRAF3IP1 MPDZ TSC1 BCL11A SLC12A5 DST PI4KA KCTD16 PLCB1 PPP1R9B DLG4 HERC2 PRRC2A ANK3 KALRN SRGAP2 PPP2R1A UBE2O PPP3CB MTOR TBK1 DOCK7 AGRN TP53BP1	3.41e-08	963	231	24	28671696
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	VAPB PI4KA AHNAK KCTD16 PPP1R9B DLG4 ANK3 KALRN SRGAP2 SRCIN1 PPP2R1A PPP3CB MTOR	6.01e-08	281	231	13	28706196
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TSC1 ZDHHC8 LRP8 PI4KA NBEAL2 EHD1 SLC35A2 CRNN PLCB1 SLITRK6 ABCC5 CPD APOB SLC3A2 PPP3CB SLC16A3 MTOR DOCK7	6.01e-08	569	231	18	30639242
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 KDM5C TSC1 GSE1 PI4KA AFG3L2 KDM2B POLK VCPIP1 DSP RBBP4 DHX40 ARHGAP17 KIAA1671 PPP2R1A TBK1 TP53BP1 HDLBP	9.80e-08	588	231	18	38580884
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRAF3IP1 DIS3L RYR3 JAK1 DST PTPRK PKD1 DLG4 HERC2 ALDH5A1 PRRC2A VCPIP1 FLNB ANK3 KALRN DSP ABCC5 UBA3 SRGAP2 ARG2 RNF220 UBE2O PPP3CB ZNF592 KDM4A IFT122 ATM	1.46e-07	1285	231	27	35914814
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	ADAM15 ST7L LRP8 JAK1 CLCA1 GSE1 PI4KA NBEAL2 KCTD16 SLC35A2 MMP3 QSOX2 HJV TRAPPC11 CARS1 LAP3 KIAA1671 UGT1A3 PPARGC1B MTOR CDH9	2.09e-07	832	231	21	36724073
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.33e-07	9	231	4	22511988
Pubmed	A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.33e-07	9	231	4	1339448
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	VAPB MPDZ ADAR PLEKHG1 AHNAK PYCR1 PPP1R9B PYCR2 PRRC2A FGD3 ARAP1 PNN RBBP4 ARHGEF5 ARHGAP17 SRGAP2 ASH2L SLC3A2 KIAA1671 PPP2R1A DOCK7 TMOD1	2.46e-07	916	231	22	32203420
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KDM5C TSC1 RYR3 MAP3K4 NBEAL2 AFG3L2 CKMT1A ANK3 CCDC187 SRCIN1 PPP2R1A DNAH12 ZNF592 VPS35 KDM4A ATM	2.64e-07	497	231	16	36774506
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ZDHHC8 JAK1 DST PTPRK FMN1 EHD1 SLC35A2 PLCB1 ANK3 ABCC5 SRGAP2 SLC3A2 SLC16A3 DOCK7	2.76e-07	377	231	14	38117590
Pubmed	Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey.	UGT1A5 UGT1A1 UGT1A3	2.89e-07	3	231	3	12051676
Pubmed	mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.	TSC1 PKD1 MTOR	2.89e-07	3	231	3	26931735
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	TRAF3IP1 DHFR UGT1A5 ABCC5 UGT1A4 UGT1A1 UGT1A3	2.91e-07	66	231	7	19898482
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	VAPB RRP1B PSMC5 ADAR PI4KA KCTD16 PYCR1 UTP20 PYCR2 CKMT1A GPI FLNB PNN DSP RBBP4 CARS1 APOB LAP3 SLC3A2 PPP2R1A UBE2O MTOR TBK1 VPS35 DOCK7 ATM HDLBP FTSJ3	3.28e-07	1425	231	28	30948266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MPDZ DPP8 LYST KIAA0753 PLEKHG1 KSR1 DST PI4KA AHNAK FOXO4 VCPIP1 DSP ARHGEF5 RALGAPB ARHGAP17 SRGAP2 KIAA1671 MLXIPL MTOR DOCK7 TNFAIP3	3.65e-07	861	231	21	36931259
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.86e-07	10	231	4	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.86e-07	10	231	4	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.86e-07	10	231	4	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.86e-07	10	231	4	22558097
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RRP1B PSMC5 ADAR ITPR3 DST SMPDL3B PI4KA AHNAK AFG3L2 UTP20 HERC2 GPI FLNB PNN DSP RBBP4 SLC3A2 KIAA1671 PPP2R1A TBK1 DOCK7 HDLBP FTSJ3	4.17e-07	1024	231	23	24711643
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RRP1B KDM5C DST TECPR2 NBEAL2 PLCB1 KDM2B ARAP1 SEMA6C SRCIN1 UBE2O AFAP1 ZNF592 IPO13 KDM4A HPS5	6.03e-07	529	231	16	14621295
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RRP1B PSMC5 TSC1 ADAR JAK1 AHNAK AFG3L2 PYCR1 PYCR2 UHRF2 RALGAPB CGGBP1 PPP2R1A TBK1 VPS35 DOCK7 HDLBP	6.72e-07	601	231	17	33658012
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MON2 VAPB BPHL PI4KA KCTD16 AFG3L2 PLCB1 PPP1R9B DLG4 PYCR2 ALDH5A1 VCPIP1 FLNB ANK3 KALRN DSP RBBP4 SRCIN1 SLC3A2 UBE2O DOCK7 TP53BP1 CYB5A HDLBP	7.19e-07	1139	231	24	36417873
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	MPDZ CCM2 FMN1 PI4KA EIF2B2 PLCB1 HERC2 PRRC2A KALRN DSP RBBP4 SNX33 PPP2R1A TP53BP1 HDLBP	8.01e-07	475	231	15	31040226
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MPDZ PSMC5 ADAR DST AGL AHNAK AMOTL1 PYCR1 PYCR2 PRRC2A GPI FLNB ANK3 DSP RBBP4 SRGAP2 ASH2L LAP3 PPP2R1A UBE2O VPS35 DOCK7 HDLBP FTSJ3	8.38e-07	1149	231	24	35446349
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.00e-07	12	231	4	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.00e-07	12	231	4	11434514
Pubmed	Defining the membrane proteome of NK cells.	IL32 MOSPD2 PSMC5 ADAR LRP8 ITPR3 KSR1 PI4KA NBEAL2 AHNAK EHD1 HERC2 CORO7 PRRC2A GPI PNN CPD SLC3A2 MTOR FHOD1 ABHD13 IFT122 GGA1 CYB5A	1.12e-06	1168	231	24	19946888
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ITPR3 PI4KA AHNAK UTP20 HERC2 PRRC2A FLNB DSP MTOR DOCK7	1.12e-06	202	231	10	33005030
Pubmed	Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.	UGT1A5 UGT1A4 UGT1A1	1.15e-06	4	231	3	18223459
Pubmed	Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.	UGT1A4 UGT1A1 UGT1A3	1.15e-06	4	231	3	9535849
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.29e-06	13	231	4	22085899
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	VAPB DST FMN1 PI4KA AHNAK EHD1 VCPIP1 FLNB ANK3 NEBL SRGAP2 SRCIN1 SLC3A2 KIAA1671 SLC16A3 HDLBP	1.42e-06	565	231	16	25468996
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MON2 KDM5C PSMC5 JAK1 PI4KA HERC2 PNN CPD ASH2L NPHP3 DOCK7 ATM	1.43e-06	313	231	12	38270169
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	VAPB MPDZ PSMC5 DST AHNAK EHD1 AFG3L2 PRRC2A VCPIP1 FLNB ANK3 DSP ABCC5 CPD SLC3A2 PPP2R1A DOCK7 HDLBP	1.44e-06	708	231	18	39231216
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	VAPB ADAM15 PSMC5 DIPK2A ITPR3 PTPRK PI4KA EIF2B2 UTP20 CORO7 QSOX2 VCPIP1 TM9SF1 CPD SLC3A2 PPP2R1A UBE2O MTOR TBK1 VPS35 HDLBP	1.53e-06	942	231	21	31073040
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	MON2 VAPB MOSPD2 TSC1 LYST LRP8 ITPR3 DST PI4KA SLC35A2 ST7 CPD SLC3A2 VPS35 TMED8	1.67e-06	504	231	15	34432599
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.80e-06	14	231	4	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.80e-06	14	231	4	10836148
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.80e-06	14	231	4	9295054
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.80e-06	14	231	4	14672974
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	MON2 VAPB GALNS MPDZ ITPR3 DST PI4KA FDXR DSP TM9SF1 SLC3A2 VPS35	1.92e-06	322	231	12	26514267
Pubmed	Multifactorial genetics of exencephaly in SELH/Bc mice.	DHFR DHFR2 FGD3 MSX2	2.44e-06	15	231	4	11598925
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	MOSPD2 TCIRG1 PSMC5 TSN LDAH LRP8 JAK1 SLC35A2 ALDH5A1 QSOX2 GPI SELENBP1 ST7 TM9SF1 CPD APOB ATP8B2 ARSL IPO13 ATM PCDH9 CYB5A	2.77e-06	1061	231	22	33845483
Pubmed	Isolation of cDNAs for mouse phenol and bilirubin UDP-glucuronosyltransferases and mapping of the mouse gene for phenol UDP-glucuronosyltransferase (Ugtla1) to chromosome 1 by restriction fragment length variations.	UGT1A5 UGT1A1 UGT1A3	2.86e-06	5	231	3	7677729
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HDHD3 RRP1B TSN TSC1 ZGPAT AGL AHNAK AFG3L2 PYCR1 PRRC2A CKMT1A VCPIP1 GPI FLNB PNN DSP CARS1 SRGAP2 SLC3A2 PPP2R1A UBE2O SLC16A3 FHOD1 VPS35 HDLBP FTSJ3	3.04e-06	1415	231	26	28515276
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.24e-06	16	231	4	19414484
Pubmed	Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns.	MPDZ BCL11A NPHP4 KDM2B DLG4 HDC	3.98e-06	63	231	6	17672918
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	VAPB MPDZ PSMC5 AMOTL1 AFG3L2 PPP1R9B HERC2 PRRC2A VCPIP1 FLNB SELENBP1 DHX40 UBA3 RNF220 UBE2O TBK1 VPS35 DOCK7 KDM4A TNFAIP3 TP53BP1	4.19e-06	1005	231	21	19615732
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	GON4L ADAR DST AHNAK FLNB PNN DSP RBBP4 DHX40 VPS35	4.20e-06	234	231	10	36243803
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.22e-06	17	231	4	20639394
Pubmed	Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.	UGT1A4 UGT1A1 UGT1A3	5.70e-06	6	231	3	19204906
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 DIS3L KDM5C BCL11A JAK1 KSR1 ZNF469 GSE1 AFG3L2 CRNN DLG4 RARS2 QSOX2 RBBP4 SKI ARG2 KIAA1671 TCHH ZNF592 TBK1 KIF18B FTSJ3	6.17e-06	1116	231	22	31753913
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	ESR2 PSMC5 ITPR3 ZGPAT FDXR EHD1 PRRC2A GPI VIL1 FLNB DSP RBBP4 ASH2L SLC3A2 UGT1A1 UBE2O HDLBP	6.38e-06	711	231	17	33022573
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	MYCBPAP DIPK2A AHNAK DHFR AMOTL1 PRRC2A CKMT1A TROAP KIAA1671 TBK1 TNFAIP3	6.41e-06	302	231	11	30561431
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.80e-06	19	231	4	23281178
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	VAPB MOSPD2 TSC1 ITPR3 DST AHNAK EHD1 SLC35A2 VCPIP1 FLNB PNN DSP SLC3A2 TMED8 HDLBP	7.05e-06	568	231	15	37774976
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MON2 VAPB MOSPD2 ADAM15 MPDZ PSMC5 TSC1 AMOTL1 CORO7 VCPIP1 NEBL MFSD9 ARHGAP17 SRGAP2 SLC3A2 UBE2O SUGP1	9.47e-06	733	231	17	34672954
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A5 UGT1A4 UGT1A1	9.93e-06	7	231	3	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A5 UGT1A1 UGT1A3	9.93e-06	7	231	3	8464825
Pubmed	Linkage of loci associated with two pigment mutations on mouse chromosome 13.	LYST DHFR DHFR2	9.93e-06	7	231	3	1682216
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MPDZ KIAA0753 PLEKHG1 KSR1 DST AMOTL1 PPP1R9B RALGAPB SRGAP2 KIAA1671 PPP2R1A TBK1 DOCK7	1.04e-05	446	231	13	24255178
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	PSMC5 GSE1 EHD1 PYCR2 VCPIP1 FLNB PNN RBBP4 SLC3A2 PPP2R1A SLC16A3 VPS35 SUGP1 TUBAL3 HDLBP FTSJ3	1.11e-05	665	231	16	30457570
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RRP1B ADAR ITPR3 DST AHNAK AMOTL1 AFG3L2 UTP20 PPP1R9B UHRF2 FLNB PNN DSP RBBP4 SLC3A2 KIAA1671 PPP2R1A AFAP1 PPP3CB FHOD1 DOCK7 HDLBP FTSJ3	1.25e-05	1257	231	23	36526897
Pubmed	Discovery and refinement of loci associated with lipid levels.	DLG4 UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3 MLXIPL DOCK7 SUGP1	1.30e-05	211	231	9	24097068
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	VAPB RRP1B MPDZ AMOTL1 EIF2B2 PPP1R9B PNN RBBP4 PPP3CB DOCK7	1.47e-05	270	231	10	24366813
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	MON2 VAPB RRP1B PI4KA AGL DHFR AFG3L2 PYCR1 RARS2 HERC2 PNN KIAA1671 MTOR TBK1 VPS35	1.51e-05	606	231	15	36538041
Pubmed	Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice.	ALPI VIL1 SI MUC2	1.52e-05	23	231	4	24680895
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	VAPB ADAR AGL DHFR AFG3L2 PYCR1 PYCR2 ALDH5A1 FLNB LAP3 SLC3A2 VPS35 DOCK7 HDLBP	1.55e-05	534	231	14	35032548
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A4 UGT1A1 UGT1A3	1.58e-05	8	231	3	20610558
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT1A4 UGT1A1 UGT1A3	1.58e-05	8	231	3	22579593
Pubmed	Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.	UGT1A4 UGT1A1 UGT1A3	1.58e-05	8	231	3	12695355
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A4 UGT1A1 UGT1A3	1.58e-05	8	231	3	17179145
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	24	231	4	24625756
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	RRP1B GON4L PSMC5 ADAR DST AHNAK AFG3L2 PRRC2A CGGBP1 UBE2O FHOD1 TUBAL3 HDLBP FTSJ3	2.02e-05	547	231	14	37267103
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	VAPB GALNS RRP1B ADAM15 PSMC5 ADAR JAK1 DST AHNAK AFG3L2 QSOX2 ALPI FLNB DSP CARS1 CPD APOB PIR PPP2R1A AFAP1 TBK1 TNFAIP3 TP53BP1	2.05e-05	1297	231	23	33545068
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	DST SMPDL3B AHNAK GPI FLNB PNN DSP RBBP4 SLC3A2 PPP2R1A UBE2O FHOD1 HDLBP	2.10e-05	477	231	13	31300519
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	VAPB MOSPD2 RRP1B MPDZ KIAA0753 ITPR3 PLEKHG1 PI4KA AFG3L2 PYCR1 HERC2 PYCR2 ANK3 RBBP4 ST7 RALGAPB CPD SLC3A2 UBE2O VPS35 IFT122 ATM TP53BP1 HDLBP FTSJ3	2.14e-05	1487	231	25	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	LHPP LRP8 SMPDL3B TECPR2 PPP1R9B POLK ARAP1 FLNB ANK3 RBBP4 ST7 FRMPD2 RALGAPB CPD SRGAP2 SRCIN1 ZMIZ1 SKI TSEN2 KIAA1671 PPARGC1B TBK1 IFT122 HPS5 CYB5A	2.19e-05	1489	231	25	28611215
Pubmed	VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.	VIL1 DSP ARHGAP17 SLC3A2 MTOR FHOD1 DOCK7 GGA1 TP53BP1 HDLBP	2.55e-05	288	231	10	23383273
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	DST GSE1 AHNAK KDM2B VCPIP1 FLNB DSP ZMIZ1 KIAA1671 ZNF592 TBK1 DOCK7	2.64e-05	418	231	12	34709266
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	PSMC5 TSN LDAH FDXR PYCR2 QSOX2 GPI FLNB DSP RBBP4 CARS1 LAP3 SLC3A2 ARG2 PPP2R1A FHOD1 VPS35 TMED8	2.67e-05	878	231	18	37223481
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	TRAF3IP1 TCIRG1 NPHP4 LRP8 PTPN7 MTMR11 DHFR HERC2 CKMT1A APOB MLXIPL PPP3CB	2.76e-05	420	231	12	28065597
Pubmed	Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.	AFG3L2 PPP1R9B DLG4 ANK3 APOB SRCIN1 PPP2R1A TMOD1 SV2C	2.84e-05	233	231	9	29518331
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MON2 KDM5C TSC1 DIPK2A KLF9 SLC35A2 CCDC140 QSOX2 HJV GPI MTF2 RALGAPB UBA3 CGGBP1 TSEN2 ASH2L TRMU MLXIPL VPS35 SUGP1 KDM4A SDHAF4 HDLBP	2.92e-05	1327	231	23	32694731
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	AHNAK PRRC2A FLNB SLC3A2 HDLBP	3.00e-05	54	231	5	25631074
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	GON4L KIAA0753 DST PI4KA AHNAK AFG3L2 PPP1R9B VCPIP1 FLNB DHX40 UBE2O ZNF592 TBK1 DOCK7 KIF18B	3.10e-05	645	231	15	25281560
Interaction	RAC1 interactions	VAPB IL32 ESR2 TSC1 NCF2 ZDHHC8 MAP3K4 JAK1 PLEKHG1 CCM2 DST PI4KA AFG3L2 UTP20 PPP1R9B DLG4 PYCR2 ARAP1 FLNB ANK3 KALRN RALGAPB ABCC5 ARHGAP17 CPD SRGAP2 SLC3A2 SLC16A3 MTOR FHOD1 DOCK7 HDLBP	3.45e-07	1063	226	32	int:RAC1
Interaction	CDC42 interactions	VAPB MOSPD2 ESR2 PSMC5 NCF2 ZDHHC8 MAP3K4 ITPR3 JAK1 PLEKHG1 PI4KA AHNAK DHFR AFG3L2 UTP20 PPP1R9B HERC2 CORO7 FGD3 ARAP1 ANK3 DSP RALGAPB ABCC5 ARHGAP17 CPD SLC3A2 PPP2R1A AFAP1 SLC16A3 SCMH1 FHOD1 DOCK7 HDLBP	5.01e-06	1323	226	34	int:CDC42
Interaction	RHOF interactions	VAPB ESR2 MPDZ ZDHHC8 CCM2 PI4KA DHFR EHD1 AFG3L2 UTP20 RARS2 ANK3 RALGAPB ABCC5 CPD SRGAP2 SLC3A2 PPP2R1A AFAP1 SLC16A3 MTOR DOCK7	7.58e-06	673	226	22	int:RHOF
Interaction	CAPZA2 interactions	ESR2 PSMC5 ITPR3 DST AHNAK AMOTL1 PPP1R9B DLG4 ARAP1 FLNB SELENBP1 KIAA1671 UBE2O AFAP1 VPS35 DOCK7 TMOD1	7.74e-06	430	226	17	int:CAPZA2
Interaction	NPY2R interactions	MON2 PI4KA FDXR RARS2 MTOR IPO13 ATM	9.02e-06	66	226	7	int:NPY2R
Interaction	CCDC8 interactions	RRP1B ITPR3 DST SMPDL3B PI4KA AHNAK AFG3L2 UTP20 HERC2 FLNB DSP RBBP4 APOB SLC3A2 KIAA1671 PPP2R1A UBE2O DNAH12 TBK1 DOCK7 HDLBP	1.68e-05	656	226	21	int:CCDC8
Interaction	YWHAH interactions	VAPB ESR2 MPDZ TSC1 DPP8 LYST KIAA0753 PLEKHG1 KSR1 DST PI4KA AHNAK PPP1R9B FOXO4 VCPIP1 TRAPPC11 PNN DSP ARHGEF5 RALGAPB ARHGAP17 SRGAP2 SNX33 KIAA1671 MLXIPL MTOR TBK1 DOCK7 TNFAIP3	1.73e-05	1102	226	29	int:YWHAH
Interaction	LRRC31 interactions	ESR2 ITPR3 PI4KA AHNAK UTP20 HERC2 PRRC2A FLNB DSP MTOR DOCK7	2.11e-05	205	226	11	int:LRRC31
Interaction	YWHAZ interactions	VAPB ESR2 TSC1 DPP8 LYST MAP3K4 KSR1 DST NBEAL2 KCTD16 AMOTL1 PPP1R9B DLG4 FOXO4 HERC2 PRRC2A TRAPPC11 ARHGEF5 RALGAPB SRGAP2 SNX33 KIAA1671 MSX2 MLXIPL PPP2R1A PPP3CB MTOR FHOD1 DOCK7 ATM TNFAIP3 TP53BP1	3.08e-05	1319	226	32	int:YWHAZ
Interaction	ARRDC4 interactions	MON2 PSMC5 JAK1 PI4KA HERC2 CPD ATM	4.10e-05	83	226	7	int:ARRDC4
Interaction	FKBP1A interactions	RYR3 AGL DHFR GPI SELENBP1 PIR MSX2 MTOR	4.12e-05	113	226	8	int:FKBP1A
Interaction	TOP3B interactions	MON2 LHPP NPHP4 ZDHHC8 LYST ITPR3 PLEKHG1 ZGPAT DST PI4KA NBEAL2 AHNAK SLC35A2 PKD1 ZER1 PPP1R9B HERC2 PRRC2A ARAP1 SEMA6C GPI KALRN ARHGAP17 APOB SRGAP2 MSX2 ZNF592 MTOR KDM4A TNFAIP3 GGA1 AGRN TP53BP1 HDLBP	4.45e-05	1470	226	34	int:TOP3B
Interaction	ATG16L1 interactions	MON2 ESR2 TSC1 KIAA0753 LRP8 ITPR3 PLEKHG1 ZGPAT AFG3L2 EIF2B2 PKD1 PYCR1 PPP1R9B CORO7 PRRC2A SYCE1 ANK3 RBBP4 ST7 DHX40 CARS1 SRGAP2 NLRP6 PPP2R1A TBK1 SUGP1 ATM HDLBP FTSJ3	4.48e-05	1161	226	29	int:ATG16L1
Interaction	USF1 interactions	ESR2 MAP3K4 AFG3L2 SYCE1 RBBP4 ASH2L LAP3	4.78e-05	85	226	7	int:USF1
Interaction	GOLGA4 interactions	TRAF3IP1 PSMC5 TSC1 ZER1 SYCE1 ASH2L MSX2 PPP2R1A VPS35 TMOD1 B3GAT1	5.16e-05	226	226	11	int:GOLGA4
Interaction	VMP1 interactions	RRP1B ESR2 DST ALPI FLNB KIAA1671 AFAP1 MTOR TMOD1 B3GAT1	5.91e-05	190	226	10	int:VMP1
Interaction	NPTN interactions	MON2 TSC1 PI4KA NBEAL2 PYCR1 UTP20 PPP1R9B HEMK1 MTOR FHOD1 IPO13 ATM	7.55e-05	278	226	12	int:NPTN
Interaction	MT1X interactions	GPI SELENBP1 PIR MSX2	7.93e-05	21	226	4	int:MT1X
Interaction	WWTR1 interactions	MPDZ ADAR AMOTL1 PRRC2A VCPIP1 ANK3 PNN ASH2L SLC3A2 KIAA1671 PPP2R1A UBE2O DOCK7 TP53BP1 HDLBP	8.94e-05	422	226	15	int:WWTR1
Interaction	SIRT7 interactions	RRP1B ESR2 PSMC5 ITPR3 DST AHNAK UTP20 HERC2 PRRC2A FLNB PNN DSP RBBP4 PPP2R1A UBE2O MTOR DOCK7 ATM TP53BP1 HDLBP FTSJ3	1.03e-04	744	226	21	int:SIRT7
Interaction	GPR55 interactions	PI4KA RARS2 ALDH5A1 TM9SF1 MTOR IPO13	1.05e-04	67	226	6	int:GPR55
Interaction	ESRRA interactions	PSMC5 DPP8 LYST KDM2B PPARGC1B IPO13	1.05e-04	67	226	6	int:ESRRA
Interaction	SIN3A interactions	ESR2 GON4L TSN BCL11A GSE1 KLF9 KDM2B MTF2 RBBP4 PIR SKI ASH2L ATM TP53BP1	1.06e-04	380	226	14	int:SIN3A
Interaction	NAA40 interactions	VAPB PSMC5 TSC1 ADAR DST GSE1 AHNAK AFG3L2 PPP1R9B PRRC2A VCPIP1 GPI NEBL PNN DSP SRGAP2 SLC3A2 KIAA1671 UBE2O FHOD1 SUGP1 TMOD1 TP53BP1 HDLBP FTSJ3	1.09e-04	978	226	25	int:NAA40
Interaction	ANK2 interactions	CHST5 PPP1R9B DLG4 HERC2 ANK3 KALRN FTSJ3	1.18e-04	98	226	7	int:ANK2
Interaction	LLGL2 interactions	ESR2 LYST PLEKHG1 GSE1 FMN1 UBE2O ZNF592 MTOR	1.30e-04	133	226	8	int:LLGL2
Interaction	FBXO22 interactions	KDM5C TSC1 RYR3 MAP3K4 NBEAL2 AFG3L2 CKMT1A ANK3 CCDC187 SRCIN1 PPP2R1A DNAH12 ZNF592 VPS35 KDM4A ATM TP53BP1	1.34e-04	540	226	17	int:FBXO22
Interaction	AGAP2 interactions	VAPB AHNAK KCTD16 PPP1R9B DLG4 ANK3 KALRN SRCIN1 PPP2R1A PPP3CB	1.35e-04	210	226	10	int:AGAP2
Interaction	HPS3 interactions	ESR2 DHFR HERC2 TRMU HPS5	1.44e-04	45	226	5	int:HPS3
Interaction	KRT8 interactions	NPHP4 KIAA0753 LRP8 ITPR3 PLEKHG1 PKD1 ZER1 PPP1R9B TRAPPC11 PNN DSP TROAP KIAA1671 TBK1 DOCK7	1.45e-04	441	226	15	int:KRT8
Interaction	TXNIP interactions	KDM5C ESR2 PI4KA AHNAK HERC2 SLC3A2 PPP2R1A UBE2O NPHP3 DOCK7	1.46e-04	212	226	10	int:TXNIP
Interaction	ARL4C interactions	PTPRK AHNAK EHD1 ABCC5 TSEN2 SLC3A2 DOCK7 PCDH9	1.52e-04	136	226	8	int:ARL4C
Cytoband	2q37	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.74e-05	31	230	4	2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	ADAM15 ADAR MTMR11 CRNN HJV SEMA6C SELENBP1 ATP8B2 TCHH EFNA3	4.20e-05	404	230	10	chr1q21
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	TRAF3IP1 ALPI UGT1A5 UGT1A4 UGT1A1 UGT1A3 HDLBP	1.55e-04	226	230	7	chr2q37
Cytoband	1q21.3	ADAM15 ADAR SELENBP1 ATP8B2 TCHH	3.21e-04	117	230	5	1q21.3
GeneFamily	UDP glucuronosyltransferases	UGT3A1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.59e-06	32	152	5	363
GeneFamily	Tudor domain containing	UHRF2 MTF2 KDM4A TP53BP1	2.56e-04	37	152	4	780
GeneFamily	PHD finger proteins	KDM5C KDM2B UHRF2 MTF2 ASH2L	9.73e-04	90	152	5	88
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5C KDM2B KDM4A	1.04e-03	24	152	3	485
GeneFamily	EF-hand domain containing\|S100 fused type protein family	CRNN TCHH	1.43e-03	7	152	2	1350
GeneFamily	CD molecules\|DASH family	DPP8 DPP7	1.43e-03	7	152	2	1205
GeneFamily	EF-hand domain containing\|Plakins	DST DSP	1.90e-03	8	152	2	939
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 FGD3 KALRN ARHGEF5	2.31e-03	66	152	4	722
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEAL2	2.43e-03	9	152	2	1230
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	GALNS RRP1B AMACR KSR1 KLF9 AGL FOXO4 HEMK1 ANK3 PNN DSP CARS1 SUGP1 TMOD1 ATM PCDH9 CYB5A	1.09e-06	475	229	17	M40979
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	MON2 TCIRG1 ITPR3 PRRC2A QSOX2 PNN ARHGAP17 RNF220 DOCK7 KDM4A	5.41e-06	184	229	10	M19988
Coexpression	GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	MOSPD2 TECPR2 AGL AFG3L2 GPI TRAPPC11 RBBP4 TBK1 VPS35 AGRN	1.13e-05	200	229	10	M299
Coexpression	LIU_SOX4_TARGETS_DN	AMACR GMPR2 MAP3K4 ITPR3 GSE1 PI4KA PPP1R9B GPI MTF2 ST7 CARS1 HDLBP	2.00e-05	310	229	12	M17287
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	LDAH SLC12A5 ITPR3 BPHL EHD1 AFG3L2 CCDC187 SNX33 TRMU IPO13	3.40e-08	179	230	10	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	BCL11A PTPRK MMP3 SLITRK6 ANK3 DSP UGT1A1 UGT1A3 CYB5A	5.88e-07	187	230	9	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 NBEAL2 FDXR ZER1 POLK GARNL3 SUGP1 HDC	2.38e-06	165	230	8	7c771f22b58989572c939ed127e637ec28dc0dca
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 LYST VNN2 EHD1 ARG2 TNFAIP3 PDCD1LG2	4.92e-06	182	230	8	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 LYST VNN2 EHD1 ARG2 TNFAIP3 PDCD1LG2	4.92e-06	182	230	8	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PADI4 NCF2 VNN2 NBEAL2 EHD1 CPD APOB SLC16A3	5.33e-06	184	230	8	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	LYST PLEKHG1 PTPRK PLCB1 SLC38A11 FLNB MLXIPL SCMH1	6.00e-06	187	230	8	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	Control-B_intermediate-10\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ADAM15 LHPP THEMIS2 ANK3 ZMIZ1 EFNA3 SUSD5 PCDH9	7.28e-06	192	230	8	224bd958369ba8fa0d7be2126f7dc61c9f6ac19d
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PADI4 TCIRG1 NCF2 LYST BPI NBEAL2 ARAP1 SLC16A3	8.15e-06	195	230	8	b0dbaae86f5703ab62f925e0f36500274044884a
ToppCell	Macroglial-Astrocytes-GFAP---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RYR3 CKMT2 GSE1 AHNAK NEBL FRMPD2 MSX2 DOCK7	9.81e-06	200	230	8	88d66550781a3c9102ff7455f5cff6fb072943cd
ToppCell	Macroglial-Astrocytes-GFAP-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RYR3 CKMT2 GSE1 AHNAK NEBL FRMPD2 MSX2 DOCK7	9.81e-06	200	230	8	d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCell	Macroglial-Astrocytes-GFAP--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RYR3 CKMT2 GSE1 AHNAK NEBL FRMPD2 MSX2 DOCK7	9.81e-06	200	230	8	16269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCell	Macroglial-Astrocytes-GFAP\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RYR3 CKMT2 GSE1 AHNAK NEBL FRMPD2 MSX2 DOCK7	9.81e-06	200	230	8	79634b1086934412ae92f259ab43554ce545008f
ToppCell	Macroglial-Astrocytes-GFAP----L1-2\|Macroglial / cells hierarchy compared to all cells using T-Statistic	RYR3 CKMT2 GSE1 AHNAK NEBL FRMPD2 MSX2 DOCK7	9.81e-06	200	230	8	c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCell	PBMC-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	BCL11A PTPRK ALDH5A1 GARNL3 TCHH CFAP74 KIF18B	1.44e-05	152	230	7	1a3f8ed476aa9a39742b4684be2c704669e4a3d0
ToppCell	facs-Lung-Endomucin_-18m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST UGT1A5 ARG2 SLC16A3 HDC	1.77e-05	157	230	7	2b60de520edf167f5ca790b478557a778435b3d9
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST UGT1A5 ARG2 SLC16A3 HDC	2.08e-05	161	230	7	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST UGT1A5 ARG2 SLC16A3 HDC	2.08e-05	161	230	7	8280a029026c272cae9649b27575831b0dd4e242
ToppCell	C_02\|World / shred on cell type and cluster	IL32 ALPI FLNB SI APOB NLRP6 CYB5A	2.44e-05	165	230	7	a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CHST5 ZNF469 SLITRK6 SLC4A9 SUSD5	2.68e-05	68	230	5	9ce22a6dea3c17d5352572ea0dabe6c6120b9f82
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CHST5 ZNF469 SLITRK6 SLC4A9 SUSD5	2.68e-05	68	230	5	89d337147899a978a7467db24e876a613bdd2288
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNS AMACR UGT3A1 VIL1 LAP3 ARG2 MTOR	2.74e-05	168	230	7	35ce3b2b9c9997d4c101da5949c7271d6a6b8f12
ToppCell	facs-Large_Intestine-Proximal\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALPI NR2E3 ABCC5 NLRP6 ARG2 UGT1A1 TUBAL3	2.74e-05	168	230	7	23e0e1592d7400012d289adb10c7598285bae2e9
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST CPD ARG2 SLC16A3 HDC	2.84e-05	169	230	7	e0076aa61b4ef3f836f5750005d0469d3982eb6d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST CPD ARG2 SLC16A3 HDC	2.84e-05	169	230	7	2341eddfedaad8cee779c37bb87f7def058588ca
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST CPD ARG2 SLC16A3 HDC	2.84e-05	169	230	7	a5964aef04093b460bbe29d5e2e7389f8fd2d46f
ToppCell	facs-Marrow-Granulocytes-18m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST CPD ARG2 SLC16A3 HDC	2.84e-05	169	230	7	94871936ccfc73b56d425373b989b87c059d4493
ToppCell	droplet-Spleen-nan-3m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 VIL1 ARHGEF5 CPD ARG2 TCHH HDC	2.95e-05	170	230	7	dbd6c9c7be824a1ff1b31af791064127cafbd194
ToppCell	facs-BAT-Fat-24m-Myeloid-granulocyte\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 EHD1 ARG2 SLC16A3 TNFAIP3 HDC	2.95e-05	170	230	7	53916d85f0d6c7e5ef3d900d6ead946f75e32567
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DIPK2A PTPRK FMN1 SLC38A11 HSPB3 FRMPD2 KCNH5	3.18e-05	172	230	7	41ddfb316429efef5f3fa0b0621ced383d9206f0
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK ALPI SELENBP1 ARHGEF5 APOB ARG2 UGT1A1	3.68e-05	176	230	7	7622f5a8e7320cc7b593141854107ecaf4adff7f
ToppCell	droplet-Marrow-nan-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 EHD1 CPD ARG2 SLC16A3 HDC	3.82e-05	177	230	7	5d70fe2b0592362d664b3b4c84eb450ec2335957
ToppCell	droplet-Marrow-nan-18m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 EHD1 CPD ARG2 SLC16A3 HDC	3.82e-05	177	230	7	48bcf603ec9593eedd81f3831cf9fde89fad368f
ToppCell	LPS_only-Myeloid-Neutrophils-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 VNN2 EHD1 ARG2 SLC16A3 TNFAIP3	4.10e-05	179	230	7	d034651a5a355a58f5e15db627869f4feebdfe35
ToppCell	droplet-Liver-LIVER-NPC-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDHD3 AMACR LHPP BPHL SELENBP1 PIR CYB5A	4.10e-05	179	230	7	10baf575f06f9a15384bcdc751446b4670acf942
ToppCell	LPS_only-Myeloid-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 VNN2 EHD1 ARG2 SLC16A3 TNFAIP3	4.10e-05	179	230	7	d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCell	NS-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AMACR CKMT2 DST SMPDL3B SEMA6C SELENBP1 DSP	4.10e-05	179	230	7	65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MPDZ RYR3 PYCR1 PIR CDH9 TUBAL3 HDC	4.40e-05	181	230	7	070ae3f3fe0e177fabcf34e64a0f158b01354837
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	PLEKHG1 PTPN7 SMPDL3B PYCR1 DSP TROAP KIF18B	4.56e-05	182	230	7	8dd79fef8f8463ad3194f9cc07c6cacf2c886304
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CKMT1A DSP TROAP ARG2 MLXIPL UBE2O NPHP3	4.72e-05	183	230	7	bbf27d2f4369031fadacacd6c432c06b1ec5abdb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 FGD3 ANK3 ARG2 PPP2R1A SLC9A4 AFAP1	5.06e-05	185	230	7	a0a629e5d2b65f670ea907bd3f5e3caf17687d8f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC38A11 SLC4A9 ANK3 NEBL ABCC5 ARG2 DOCK7	5.60e-05	188	230	7	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 HJV HSPB3 ANK3 NEBL DSP TMOD1	5.79e-05	189	230	7	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 HJV HSPB3 ANK3 NEBL DSP TMOD1	5.79e-05	189	230	7	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MPDZ RYR3 PYCR1 PIR CDH9 TUBAL3 HDC	5.79e-05	189	230	7	6687a93ac8540ece5fd762f6f77c1f25f159195b
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	ADAM15 LYST PLEKHG1 GSE1 PLCB1 KALRN KIAA1671	5.98e-05	190	230	7	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	RYR3 SELENBP1 NEBL FRMPD2 CCDC187 DNAH12 CFAP74	6.18e-05	191	230	7	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 DHFR SLC38A11 FGD3 ARG2 SLC9A4 AGRN	6.18e-05	191	230	7	0a0719a0a49ae0099d61e22585ac74c10c24b4a2
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	RYR3 SELENBP1 NEBL FRMPD2 CCDC187 DNAH12 CFAP74	6.18e-05	191	230	7	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITPR3 SMPDL3B PTPRK NBEAL2 ANK3 NEBL CYB5A	6.39e-05	192	230	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	DST PLCB1 SEMA6C ZMIZ1 SLC16A3 TNFAIP3 PCDH9	6.39e-05	192	230	7	e16035b3328f9b1b2e28d234c62ba88387540550
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PTPRK PLCB1 VIL1 FLNB DSP MLXIPL SCMH1	6.60e-05	193	230	7	503a979328c68b096680b71359a26f02fafdff35
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 SLC38A11 FGD3 ANK3 ARG2 SLC9A4 AGRN	6.60e-05	193	230	7	e7012f7b53971972299db34fa51ff51a4e4987fe
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL11A PLEKHG1 PTPRK SLC38A11 DSP PCDH9 CYB5A	6.60e-05	193	230	7	cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ITPR3 PTPRK SELENBP1 ANK3 NEBL PCDH9 CYB5A	6.60e-05	193	230	7	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC12A5 DLG4 HERC2 CKMT1A RNF220 UBE2O EFNA3	6.82e-05	194	230	7	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL11A PLEKHG1 PTPRK QSOX2 DSP CCDC187 PCDH9	6.82e-05	194	230	7	e9c907b8ec4329946338cca5ce8e954fa2cec37b
ToppCell	COVID-19_Moderate-B_naive\|World / disease group, cell group and cell class	BCL11A PLEKHG1 PTPRK SLC38A11 DSP PCDH9 CYB5A	6.82e-05	194	230	7	1f81d618799e482a36dce528bba70f52cc69a901
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	DST FDXR ARHGEF5 IPO13 PCDH9 SDHAF4 TP53BP1	6.82e-05	194	230	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	DST FDXR ARHGEF5 IPO13 PCDH9 SDHAF4 TP53BP1	6.82e-05	194	230	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NCF2 LYST VNN2 DPEP2 FGD3 THEMIS2 SRGAP2	7.04e-05	195	230	7	1d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HDHD3 AMACR CLCA1 VIL1 DSP ARSL MUC2	7.27e-05	196	230	7	79bc7ab96b52b2a542348a13ddd0a4f095698c5e
ToppCell	Control-Myeloid-TRAM3\|Control / Disease group,lineage and cell class （2021.01.30）	PDGFRL TCIRG1 THEMIS2 GPI LAP3 SLC3A2 HDLBP	7.51e-05	197	230	7	733ff40039d67e561c2ded7c9bd0b4353101741e
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MAP3K4 LRP8 UHRF2 ANK3 PNN SLC9A4 ATM	7.51e-05	197	230	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	BAL-Control-Myeloid-TRAM-TRAM3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDGFRL TCIRG1 THEMIS2 GPI LAP3 SLC3A2 HDLBP	7.51e-05	197	230	7	0f1c4a328968b32874e6ebb0803e665adcbbc450
ToppCell	Influenza-Influenza_Severe-Myeloid-pDC\|Influenza_Severe / Disease, condition lineage and cell class	BCL11A ZNF469 DST AMOTL1 ALDH5A1 FLNB SCMH1	7.51e-05	197	230	7	e8e6f71e6dc8a695e4321a18543c1df63dd62f3e
ToppCell	BAL-Control-Myeloid-TRAM-TRAM3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDGFRL TCIRG1 THEMIS2 GPI LAP3 SLC3A2 HDLBP	7.51e-05	197	230	7	4416efdbd9c4ac3356a5dff2d535c2d7383376a9
ToppCell	BAL-Control-Myeloid-TRAM-TRAM3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDGFRL TCIRG1 THEMIS2 GPI LAP3 SLC3A2 HDLBP	7.51e-05	197	230	7	aafe0cd697b0b7f0756596148e0906443fdf8ef7
ToppCell	BAL-Control-Myeloid-TRAM-TRAM3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDGFRL TCIRG1 THEMIS2 GPI LAP3 SLC3A2 HDLBP	7.51e-05	197	230	7	e131634bc67e0bd31a938a8e8df8dc752e1d0f47
ToppCell	CV-Severe-1\|CV / Virus stimulation, Condition and Cluster	IL32 ADAR LYST PTPN7 THEMIS2 LAP3 SLC16A3	7.75e-05	198	230	7	fc0e885e370ffb780eada62bb2b52065c2f8b26b
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	NBEAL2 FGD3 ALPI SELENBP1 DSP FHOD1 HPS5	7.75e-05	198	230	7	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PADI4 TCIRG1 NCF2 VNN2 FGD3 GPI SLC16A3	8.00e-05	199	230	7	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PADI4 TCIRG1 NCF2 LYST VNN2 ARG2 TNFAIP3	8.00e-05	199	230	7	8c2ab13b5fffbab3da37041a7000d6537fc4db09
ToppCell	10x5'v1-week_17-19-Myeloid_monocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PADI4 NCF2 LYST MTMR11 AHNAK THEMIS2 SLC16A3	8.00e-05	199	230	7	aa30a57c0907d012942e7babdbff6ea4d01d7798
ToppCell	10x5'v1-week_17-19-Myeloid_monocytic-monocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PADI4 NCF2 LYST MTMR11 AHNAK THEMIS2 SLC16A3	8.00e-05	199	230	7	7e5a56bb2ac441a8fa4ad0b928f9c0c82d128190
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ALPI VIL1 SI APOB UGT1A1 MLXIPL CYB5A	8.00e-05	199	230	7	01c2721bc82cd672e9477029b4a7ecc77e2f1b00
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PADI4 TCIRG1 NCF2 VNN2 FGD3 GPI SLC16A3	8.00e-05	199	230	7	caf2e050b21e7a16ce4e51b3f135debd06810231
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Unfolded_protein_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	IL32 VIL1 DSP APOB MLXIPL ARSL SLC16A3	8.25e-05	200	230	7	12078bc25be67180c0f4b37fef921cdcd1003576
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PADI4 TCIRG1 NCF2 LYST VNN2 NBEAL2 ARG2	8.25e-05	200	230	7	fd1b6db3c62f5a205b769ba0e61433dae6285b67
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NCF2 BCL11A PLEKHG1 VNN2 DPEP2 PPP1R9B SLC38A11	8.25e-05	200	230	7	4f7be296be0cd54cfc62cc93263fde26210c61f4
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PADI4 TCIRG1 NCF2 LYST VNN2 ARG2 TNFAIP3	8.25e-05	200	230	7	1592ca96c59eb053d0f0915afb337db9f3a40c91
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TRAF3IP1 AHNAK SELENBP1 ANK3 NEBL DSP CYB5A	8.25e-05	200	230	7	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TCIRG1 ZGPAT PTPN7 ARAP1 THEMIS2 GPI SLC16A3	8.25e-05	200	230	7	5f1de1f9305e1784c12d526f6c8bdd7d56229f9b
ToppCell	MS-IIF-Myeloid-cDC\|IIF / Disease, condition lineage and cell class	ADAM15 NCF2 MTMR11 DST AHNAK SRGAP2 LAP3	8.25e-05	200	230	7	620a82805619d113182d59740670c9f9b93ee924
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PADI4 TCIRG1 NCF2 LYST VNN2 NBEAL2 ARG2	8.25e-05	200	230	7	0b7573ec4e9c67c7d11dd8f5011a70bade30e930
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HDHD3 UGT3A1 VIL1 DSP SI APOB ARSL	8.25e-05	200	230	7	0ca955b71b97571b45e9e89004f1d0bb9fc9e67b
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CHST5 ZNF469 SLITRK6 SLC4A9 SUSD5	1.03e-04	90	230	5	a0baaf2b3cf07d457f0d242fc213689cba6fd449
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CHST5 ZNF469 SLITRK6 SLC4A9 SUSD5	1.03e-04	90	230	5	ab4b08c6ac8695b38f841c0ecf2bb2c032111d04
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PDGFRL MMP3 SYCE1 SEMA6C CCDC187 TTLL8	1.08e-04	145	230	6	ac41c6c02b7d78162b86222983688f54d04ac47d
ToppCell	facs-Trachea-nan-3m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 NCF2 LYST ARG2 SLC16A3 HDC	1.25e-04	149	230	6	9c4837aa63e46382ff45a41c72beb5722b3ada19
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 BCL11A LYST ATP8B2 SLC9A4 SLC16A3	1.25e-04	149	230	6	48fca6ae33d7722c024b43ce04f4dbce7b6b424b
ToppCell	droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PADI4 NCF2 LYST ARG2 SLC16A3 HDC	1.44e-04	153	230	6	ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0
ToppCell	droplet-Lung-3m-Hematologic-myeloid-neutrophil\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PADI4 NCF2 LYST ARG2 SLC16A3 HDC	1.44e-04	153	230	6	9dba38574908f31a1194b8a339868f5e4be1be71
ToppCell	Control-Myeloid-Neutrophils-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 BPI VNN2 ARG2 SLC16A3	1.44e-04	153	230	6	e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd
ToppCell	facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCF2 LYST FGD3 ARG2 SLC16A3 HDC	1.44e-04	153	230	6	338684d420b01e32918fa19048ccdda234942ce1
ToppCell	Control-Myeloid-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NCF2 BPI VNN2 ARG2 SLC16A3	1.44e-04	153	230	6	c33d63b2d1a220bc428e776b157b23faa43ea8ca
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 DPEP2 AHNAK EHD1 PLCB1 SLC9A4	1.60e-04	156	230	6	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	facs-Lung-EPCAM-24m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 SLC4A9 ARG2 MSX2 SLC16A3 HDC	1.66e-04	157	230	6	d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 SLC4A9 ARG2 MSX2 SLC16A3 HDC	1.66e-04	157	230	6	350069e4d2dbddc82e813e2a2cc43032daa23605
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRP1B MPDZ GARNL3 NEBL AFAP1 KDM4A	1.66e-04	157	230	6	370f44047ef438b8f1124c2c2761c150c0d8c57f
Drug	AC1L9E0Q	SLC35A2 UGT1A5 ABCC5 UGT1A4 UGT1A1 UGT1A3 KCNH5	1.54e-08	30	228	7	CID000443095
Drug	AC1O5XMV	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.24e-08	11	228	5	CID006442661
Drug	Benzamidoxime hydrochloride	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A	4.52e-08	21	228	6	CID000069186
Drug	ASA404	GMPR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 TBK1 CYB5A	5.38e-08	53	228	8	CID000123964
Drug	N-OH-DABZ	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.21e-08	12	228	5	CID000051366
Drug	2,4,6-TCB	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.21e-08	12	228	5	CID000037247
Drug	amidoxime	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A	8.27e-08	23	228	6	CID000465967
Drug	THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A	ITPR3 SMPDL3B FDXR ALDH5A1 ARAP1 ST7 CPD CDK10 TRMU DHRS12 TCHH SUGP1 TMOD1	1.16e-07	199	228	13	6511_DN
Drug	5-azido-UDP-glucuronic acid	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.16e-07	13	228	5	CID003081279
Drug	cotinine-N-glucuronide	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.16e-07	13	228	5	CID000000411
Drug	PCB-61	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.79e-07	14	228	5	CID000036401
Drug	anthraflavic acid	ESR2 SLC35A2 UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3	2.58e-07	44	228	7	CID000006776
Drug	afloqualone	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.67e-07	15	228	5	CID000002040
Drug	naphthyl sulphate	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.67e-07	15	228	5	CID000114775
Drug	coumarin-3-carboxylic acid	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.67e-07	15	228	5	CID000010752
Drug	7-hydroxy-4-trifluoromethylcoumarin	ESR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.70e-07	29	228	6	CID005375667
Drug	1'-hydroxyestragole	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.85e-07	16	228	5	CID000040003
Drug	tolcapone	GMPR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.59e-07	30	228	6	CID004659569
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.41e-07	17	228	5	CID000003573
Drug	6-hydroxychrysene	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	5.41e-07	17	228	5	CID000037766
Drug	ethyl-beta-D-6-glucosiduronic acid	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.43e-07	18	228	5	CID000152226
Drug	2,3,7-trichlorodibenzo-p-dioxin	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.43e-07	18	228	5	CID000036614
Drug	ApApG	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.43e-07	18	228	5	CID003081975
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	VAPB RRP1B LHPP BPHL TECPR2 KLF9 ARAP1 CPD CDK10 TCHH SUGP1 ATM	8.00e-07	198	228	12	6459_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	TRAF3IP1 LHPP NCF2 BCL11A TECPR2 MTF2 MFSD9 ARG2 SLC16A3 ATM GGA1 HDLBP	8.43e-07	199	228	12	5838_DN
Drug	5alpha-spirostan-3beta-ol	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.00e-06	19	228	5	CID000091433
Drug	estragole	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 MTOR	1.00e-06	34	228	6	CID000008815
Drug	pheophytin	GALNS AMACR UGT3A1 CKMT2 SLC35A2 ALPI CKMT1A UGT1A5 ABCC5 LAP3 UGT1A4 UGT1A1 UGT1A3 CYB5A	1.16e-06	284	228	14	CID000000250
Drug	AC1MRQNQ	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.19e-06	9	228	4	CID003522271
Drug	DHPASiU	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.19e-06	9	228	4	CID000197602
Drug	3-iodophenol	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.19e-06	9	228	4	CID000012272
Drug	AC1L4J7U	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.19e-06	9	228	4	CID000186631
Drug	Chebi:32663	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.19e-06	9	228	4	CID005460873
Drug	AC1L1OBF	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.32e-06	20	228	5	CID000032736
Drug	muraglitazar	SLC35A2 UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3	1.43e-06	36	228	6	CID000206044
Drug	l-borneol	GALNS SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.69e-06	37	228	6	CID000010049
Drug	dulcin	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.72e-06	21	228	5	CID000009013
Drug	phenylbutazone	CKMT2 SLC35A2 CKMT1A UGT1A5 UGT1A4 UGT1A1 UGT1A3 HDC	1.85e-06	83	228	8	CID000004781
Drug	4-methylumbelliferyl glucuronide	SLC35A2 GPI UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.99e-06	38	228	6	CID000091553
Drug	amonafide	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.21e-06	22	228	5	CID000050515
Drug	N-methylpiperazine	UGT1A5 CPD UGT1A4 UGT1A1 UGT1A3	2.21e-06	22	228	5	CID000053167
Drug	estradiol-3-glucuronide	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.80e-06	23	228	5	CID000066651
Drug	alpha-naphthoflavone	GALNS ESR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A HDLBP	3.00e-06	118	228	9	CID000011790
Drug	4-nitrophenyl)imidazole	UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.06e-06	11	228	4	CID000123155
Drug	2-hydroxyestradiol	ESR2 SLC35A2 SELENBP1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.16e-06	63	228	7	CID000009684
Drug	AS-3201	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	3.51e-06	24	228	5	CID000153948
Drug	L 654969	SLC35A2 UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3	3.66e-06	42	228	6	CID000005218
Drug	Tetracycline	GALNS AMACR UGT3A1 GMPR2 NPHP4 LDAH JAK1 PTPN7 MTMR11 KLF9 HEMK1 MMP3 HJV NR2E3 HSPB3 APOB PIR ATP8B2 CFAP74 GGA1 CYB5A	4.08e-06	668	228	21	ctd:D013752
Drug	androsterone glucuronide	SLC35A2 UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3	4.22e-06	43	228	6	CID000114833
Drug	AzMC	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.35e-06	25	228	5	CID000064986
Drug	N-acetylbenzidine	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.35e-06	25	228	5	CID000018787
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.55e-06	12	228	4	CID000088735
Drug	nonanoyl-N-methylglucamide	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.55e-06	12	228	4	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.55e-06	12	228	4	CID000276709
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	KDM5C TSN PLCB1 ALDH5A1 PRRC2A FLNB CDK10 SLC16A3 SCMH1 TMOD1 ATM	5.36e-06	198	228	11	2749_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A	ITPR3 EHD1 SLC35A2 ARAP1 NEBL ST7 ATP8B2 TRMU DHRS12 AFAP1 TMOD1	5.63e-06	199	228	11	6492_DN
Drug	diflunisal	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.50e-06	27	228	5	CID000003059
Drug	tritanol	UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.52e-06	13	228	4	CID000006457
Drug	3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid	AMACR UGT3A1 CLCA1 SLC35A2 ALPI UGT1A5 LAP3 UGT1A4 UGT1A1 UGT1A3 TNFAIP3	7.82e-06	206	228	11	CID000005645
Drug	CARMINE	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.85e-06	28	228	5	CID000014749
Drug	H-Ni	MMP3 UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.85e-06	28	228	5	CID000445665
Drug	salicylamide	FDXR SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	8.15e-06	48	228	6	CID000005147
Drug	retigabine	SLC35A2 ANK3 UGT1A5 UGT1A4 UGT1A1 UGT1A3	8.15e-06	48	228	6	CID000121892
Drug	propranolol glucuronide	UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.06e-06	14	228	4	CID000119515
Drug	glucosiduronate	GALNS UGT3A1 SLC35A2 HJV UGT1A5 ABCC5 UGT1A4 UGT1A1 UGT1A3 B3GAT1	9.21e-06	171	228	10	CID000000610
Drug	EM-652	ESR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.21e-06	49	228	6	CID000155435
Drug	campestrol	UGT1A5 CPD APOB UGT1A4 UGT1A1 UGT1A3	9.21e-06	49	228	6	CID000010134
Drug	trans-3'-hydroxycotinine	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	9.41e-06	29	228	5	CID000000414
Drug	iberin	UGT1A5 SI UGT1A4 UGT1A1 UGT1A3	9.41e-06	29	228	5	CID000010455
Drug	naringenin	ESR2 LYST SLC35A2 UGT1A5 ABCC5 APOB UGT1A4 UGT1A1 UGT1A3	9.62e-06	136	228	9	CID000000932
Drug	p,p'-hydroxy-DDT	ESR2 FDXR UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.04e-05	50	228	6	CID000076302
Drug	paricalcitol	ALPI UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.12e-05	30	228	5	CID005281104
Drug	dihydroartemisinin	UGT1A5 UGT1A4 UGT1A1 UGT1A3 ATM	1.12e-05	30	228	5	CID000107770
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.23e-05	15	228	4	CID000040469
Drug	sulforaphane nitrile	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.23e-05	15	228	4	CID000543743
Drug	4-nitrophenol	GALNS UGT3A1 SLC35A2 ALPI UGT1A5 UGT1A4 UGT1A1 UGT1A3 KCNMB3 CYB5A	1.25e-05	177	228	10	CID000000980
Drug	AC1NQGK1	SLC35A2 UGT1A5 ABCC5 UGT1A4 UGT1A1 UGT1A3	1.31e-05	52	228	6	CID005195977
Drug	PCB 156	UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A	1.32e-05	31	228	5	CID000038019
Drug	4'-HPPH	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.32e-05	31	228	5	CID000017732
Drug	4-hydroxyestradiol	ESR2 SLC35A2 SELENBP1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.45e-05	79	228	7	CID000001743
Drug	NNAL	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.56e-05	32	228	5	CID000104856
Drug	ammonia	PADI4 GALNS GMPR2 ADAR LYST FDXR PKD1 ALDH5A1 GPI UGT1A5 LAP3 ARG2 UGT1A4 UGT1A1 UGT1A3 MLXIPL TUBAL3	1.62e-05	509	228	17	CID000000222
Drug	quercetin-3,4'-diglucoside	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.62e-05	16	228	4	CID005320835
Drug	bilirubin-phosphate	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.62e-05	16	228	4	CID005497144
Drug	erythromycin stearate	DHFR GPI UGT1A5 UGT1A4 UGT1A1 UGT1A3 AFAP1 AGRN	1.63e-05	111	228	8	CID000012559
Drug	tangeretin	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A	1.63e-05	54	228	6	CID000068077
Drug	adenine	GALNS NCF2 GMPR2 ADAR RYR3 CKMT2 DHFR FDXR SLC35A2 HEMK1 POLK CKMT1A NR2E3 TRMU MTOR HPS5 CYB5A	1.66e-05	510	228	17	CID000000190
Drug	ezetimibe	CKMT2 SLC35A2 UHRF2 CKMT1A UGT1A5 APOB UGT1A4 UGT1A1 UGT1A3	1.80e-05	147	228	9	CID000150311
Drug	AC1Q6OQF	ESR2 SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	55	228	6	CID000009685
Drug	R(-)-Denopamine	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	33	228	5	CID000003818
Drug	norbuprenorphine	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	33	228	5	CID000114976
Drug	BP-3,6-quinol	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	33	228	5	CID000119292
Drug	geniposide	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.82e-05	33	228	5	CID000107848
Drug	Udpxylose	GALNS UGT3A1 SLC35A2	1.94e-05	6	228	3	CID006857349
Drug	alpha-hydroxybutyrate	LYST CKMT2 ALPI CKMT1A GPI LAP3	2.02e-05	56	228	6	CID000011266
Drug	DNCB	LYST SLC35A2 UGT1A5 ABCC5 ARG2 UGT1A4 UGT1A1 UGT1A3 TNFAIP3 CYB5A	2.20e-05	189	228	10	CID000000006
Drug	lamotrigine	RYR3 ITPR3 SLC35A2 PKD1 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.25e-05	116	228	8	CID000003878
Drug	AC1NOWCJ	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.45e-05	35	228	5	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT1A5 UGT1A4 UGT1A1 UGT1A3 CYB5A	2.45e-05	35	228	5	CID010436171
Drug	estrone-3-glucuronide	SLC35A2 UGT1A5 UGT1A4 UGT1A1 UGT1A3	2.45e-05	35	228	5	CID000115255
Disease	X-11442 measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.17e-07	9	227	4	EFO_0021236
Disease	X-11441 measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.17e-07	9	227	4	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.17e-07	9	227	4	EFO_0004739
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A5 UGT1A4 UGT1A1 UGT1A3	4.17e-07	9	227	4	EFO_0004570, GO_0009410
Disease	bilirubin measurement, response to tenofovir	UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.91e-07	10	227	4	EFO_0004570, EFO_0009279
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.91e-07	10	227	4	EFO_0802185
Disease	histidine betaine (hercynine) measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.08e-06	11	227	4	EFO_0800972
Disease	X-21796 measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.08e-06	11	227	4	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.08e-06	11	227	4	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.08e-06	11	227	4	EFO_0010219
Disease	biliverdin measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	1.61e-06	12	227	4	EFO_0021033
Disease	Malignant neoplasm of breast	ESR2 BCL11A ADAR DHFR SLC35A2 PLCB1 UTP20 MMP3 HERC2 PRRC2A THEMIS2 GPI FLNB KALRN WDR88 MFSD9 ZMIZ1 PPARGC1B SLC16A3 MTOR ATM GGA1 TP53BP1 HDLBP	3.21e-06	1074	227	24	C0006142
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.50e-06	17	227	4	EFO_0004611, EFO_0007800
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 AGRN TP53BP1	9.14e-06	63	227	6	EFO_0022292
Disease	Colorectal Carcinoma	GALNS PDGFRL AMACR ESR2 PSMC5 ZNF232 ABCA10 SLC12A5 GSE1 DHFR UHRF2 SELENBP1 KALRN FRMPD2 ABCC5 APOB ZMIZ1 HDC	9.46e-06	702	227	18	C0009402
Disease	triglycerides in large LDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.96e-05	43	227	5	EFO_0022319
Disease	Succinimide measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0022118
Disease	cholelithiasis, bilirubin measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0004570, EFO_0004799
Disease	X-24849 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0800909
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0802740
Disease	X-16946 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0800766
Disease	X-11793--oxidized bilirubin measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0021260
Disease	X-11530 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0801034
Disease	X-11522 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0800696
Disease	X-10458 measurement	UGT1A5 UGT1A4 UGT1A3	2.45e-05	8	227	3	EFO_0800692
Disease	saturated fatty acids measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	2.45e-05	45	227	5	EFO_0022304
Disease	platelet component distribution width	ST7L GSE1 KLF9 PLCB1 PPP1R9B POLK PRRC2A FGD3 THEMIS2 KALRN ABCC5 ZMIZ1 SKI MLXIPL UBE2O DOCK7 SUGP1 SDHAF4	2.49e-05	755	227	18	EFO_0007984
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A5 UGT1A4 UGT1A3	3.65e-05	9	227	3	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A5 UGT1A4 UGT1A3	3.65e-05	9	227	3	EFO_0801036
Disease	X-11880 measurement	UGT1A5 UGT1A4 UGT1A3	3.65e-05	9	227	3	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A5 UGT1A4 UGT1A3	3.65e-05	9	227	3	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A5 UGT1A4 UGT1A3	3.65e-05	9	227	3	EFO_0802127
Disease	phospholipids in very small VLDL measurement	ABCA10 APOB DOCK7 SUGP1 TP53BP1	4.54e-05	51	227	5	EFO_0022300
Disease	Intellectual Disability	KDM5C GON4L BCL11A SLC35A2 PYCR1 DLG4 PYCR2 ALDH5A1 ZMIZ1 TSEN2 CDK10 PPP2R1A MTOR	4.78e-05	447	227	13	C3714756
Disease	X-21448 measurement	UGT1A5 UGT1A4 UGT1A3	5.18e-05	10	227	3	EFO_0800816
Disease	X-23974 measurement	UGT1A5 UGT1A4 UGT1A3	5.18e-05	10	227	3	EFO_0800867
Disease	triglycerides in HDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	5.48e-05	53	227	5	EFO_0022317
Disease	Schizophrenia	AMACR ESR2 BCL11A ZDHHC8 LRP8 SLC12A5 PI4KA PLCB1 KDM2B PPP1R9B DLG4 MMP3 SELENBP1 ANK3 UGT1A3 MTOR VPS35 B3GAT1 ATM	5.89e-05	883	227	19	C0036341
Disease	autosomal recessive cutis laxa type IIB (implicated_via_orthology)	PYCR1 PYCR2	5.89e-05	2	227	2	DOID:0070137 (implicated_via_orthology)
Disease	triglycerides in medium HDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	6.00e-05	54	227	5	EFO_0022321
Disease	cholelithiasis	ADAR UGT1A5 UGT1A4 UGT1A1 UGT1A3 MLXIPL	6.22e-05	88	227	6	EFO_0004799
Disease	xanthurenate measurement	UGT1A5 UGT1A4 UGT1A1 UGT1A3	6.97e-05	29	227	4	EFO_0010551
Disease	triglycerides in LDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	7.16e-05	56	227	5	EFO_0022320
Disease	triglycerides in very large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	7.16e-05	56	227	5	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	APOB MLXIPL DOCK7 SUGP1 TP53BP1	7.16e-05	56	227	5	EFO_0022333
Disease	cholesteryl esters to total lipids in medium HDL percentage	APOB MLXIPL DOCK7 SUGP1 TP53BP1	7.16e-05	56	227	5	EFO_0022251
Disease	response to dolutegravir	UGT1A5 UGT1A4 UGT1A1 UGT1A3	7.99e-05	30	227	4	EFO_0600017
Disease	triglycerides in IDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	8.48e-05	58	227	5	EFO_0022149
Disease	triglycerides in VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	9.20e-05	59	227	5	EFO_0022326
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	APOB MLXIPL DOCK7 SUGP1 AGRN	9.20e-05	59	227	5	EFO_0022260
Disease	p-cresol glucuronide measurement	UGT1A5 UGT1A4 UGT1A3	9.39e-05	12	227	3	EFO_0800079
Disease	Renal dysplasia and retinal aplasia (disorder)	TRAF3IP1 NPHP4 NPHP3	9.39e-05	12	227	3	C0403553
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	9.98e-05	60	227	5	EFO_0021898
Disease	cholesterol to total lipids in medium HDL percentage	APOB MLXIPL DOCK7 SUGP1 TP53BP1	9.98e-05	60	227	5	EFO_0022237
Disease	triglycerides in small VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.08e-04	61	227	5	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.08e-04	61	227	5	EFO_0022274
Disease	triglycerides in small HDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.17e-04	62	227	5	EFO_0022158
Disease	triglycerides in medium LDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.17e-04	62	227	5	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.17e-04	62	227	5	EFO_0022339
Disease	total lipids in chylomicrons and extremely large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 AGRN	1.17e-04	62	227	5	EFO_0022306
Disease	total lipids in very large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.17e-04	62	227	5	EFO_0022313
Disease	phospholipids in very large VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.17e-04	62	227	5	EFO_0022299
Disease	retinol dehydrogenase 16 measurement	UGT1A5 UGT1A4 UGT1A3	1.21e-04	13	227	3	EFO_0802007
Disease	free cholesterol to total lipids in medium LDL percentage	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.26e-04	63	227	5	EFO_0022283
Disease	triglycerides in small LDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.46e-04	65	227	5	EFO_0022323
Disease	C-reactive protein measurement	ADAR JAK1 ZGPAT ZNF469 AHNAK PKD1 KDM2B DLG4 SLITRK6 ARAP1 SEMA6C ANK3 MTF2 APOB ZMIZ1 ATP8B2 MLXIPL SLC9A4 SPATA16 DOCK7 TP53BP1 HDLBP	1.71e-04	1206	227	22	EFO_0004458
Disease	Isolated focal cortical dysplasia type II	TSC1 MTOR	1.76e-04	3	227	2	cv:C1846385
Disease	Focal Cortical Dysplasia of Taylor, Type IIb	TSC1 MTOR	1.76e-04	3	227	2	C1846389
Disease	FOCAL CORTICAL DYSPLASIA OF TAYLOR	TSC1 MTOR	1.76e-04	3	227	2	C1846385
Disease	Focal Cortical Dysplasia of Taylor, Type IIa	TSC1 MTOR	1.76e-04	3	227	2	C1846386
Disease	FOCAL CORTICAL DYSPLASIA, TYPE II	TSC1 MTOR	1.76e-04	3	227	2	607341
Disease	triglycerides in very small VLDL measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.81e-04	68	227	5	EFO_0022144
Disease	triglycerides to phosphoglycerides ratio	APOB MLXIPL DOCK7 SUGP1 TP53BP1	1.81e-04	68	227	5	EFO_0022327
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB MLXIPL DOCK7 SUGP1	1.85e-04	37	227	4	EFO_0022252
Disease	schizophrenia (biomarker_via_orthology)	KDM5C ASH2L PPP3CB	1.91e-04	15	227	3	DOID:5419 (biomarker_via_orthology)
Disease	Benign neoplasm of bladder	TSC1 MTOR ATM	1.91e-04	15	227	3	C0154017
Disease	Carcinoma in situ of bladder	TSC1 MTOR ATM	1.91e-04	15	227	3	C0154091
Disease	platelet storage pool deficiency (implicated_via_orthology)	LYST DOCK7 HPS5	1.91e-04	15	227	3	DOID:2223 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	TSC1 MTOR ATM	1.91e-04	15	227	3	C0496930
Disease	gallstones	ADAR UGT1A5 UGT1A4 UGT1A1 UGT1A3 MLXIPL	1.93e-04	108	227	6	EFO_0004210
Disease	Epilepsy	KDM5C TSC1 SLC12A5 SLC35A2 RARS2 KCNH5	2.03e-04	109	227	6	C0014544
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	TSC1 PKD1 MTOR	2.34e-04	16	227	3	DOID:0110861 (implicated_via_orthology)
Disease	cholesterol in very small VLDL measurement	ABCA10 APOB DOCK7 SUGP1	2.51e-04	40	227	4	EFO_0022231
Disease	free cholesterol to total lipids in large LDL percentage	POLK APOB MLXIPL DOCK7 TP53BP1	2.70e-04	74	227	5	EFO_0022280
Disease	serum gamma-glutamyl transferase measurement	ADAM15 GON4L GSE1 NBEAL2 AHNAK PKD1 KDM2B ZER1 PRRC2A KALRN MTF2 ZMIZ1 SKI MLXIPL SLC9A4 EFNA3 TP53BP1 HDLBP	2.74e-04	914	227	18	EFO_0004532
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB MLXIPL DOCK7 TP53BP1	3.33e-04	43	227	4	EFO_0022290
Disease	angiopoietin-related protein 1 measurement	UGT1A5 UGT1A4 UGT1A3	3.37e-04	18	227	3	EFO_0801382
Disease	Carcinoma of bladder	TSC1 MTOR ATM	3.37e-04	18	227	3	C0699885
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	APOB MLXIPL DOCK7 SUGP1 TP53BP1	3.45e-04	78	227	5	EFO_0022187
Disease	arabitol measurement, xylitol measurement	SAMD15 ATP8B2	3.50e-04	4	227	2	EFO_0800148, EFO_0801067
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	PKD1 MTOR	3.50e-04	4	227	2	DOID:898 (is_implicated_in)
Disease	cutaneous melanoma	FMN1 HERC2 CORO7 CDK10 PPARGC1B ATM	3.57e-04	121	227	6	EFO_0000389
Disease	total lipids in very small VLDL measurement	ABCA10 APOB DOCK7 SUGP1	3.97e-04	45	227	4	EFO_0022156
Disease	Celiac Disease	MMP3 APOB ZMIZ1 UGT1A4	4.69e-04	47	227	4	C0007570
Disease	free cholesterol in very small VLDL measurement	ABCA10 APOB DOCK7 SUGP1	4.69e-04	47	227	4	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	ABCA10 APOB MLXIPL DOCK7	4.69e-04	47	227	4	EFO_0022269
Disease	tissue factor measurement	UGT1A5 UGT1A4 UGT1A3	5.39e-04	21	227	3	EFO_0010623
Disease	non-alcoholic fatty liver disease	PLCB1 ZMIZ1 TSEN2 MLXIPL EFNA3 DOCK7 SUGP1	5.44e-04	182	227	7	EFO_0003095
Disease	Progeria	PYCR1 ANK3	5.80e-04	5	227	2	C0033300

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELPVKHPELFEALGI	PSMC5	166	P62195
SLHKDRPVEPLDLAV	UGT1A3	446	P35503
PTGIPHENIFIRTKD	ABHD13	81	Q7L211
PSDLEAHFVPLVKRL	PPP2R1A	121	P30153
PLLAVHKDEGSDPRR	B3GAT1	31	Q9P2W7
RSIPEKGLEPEHSFS	SLC4A9	946	Q96Q91
SKPRGFPEEGHVDVK	CCDC187	941	A0A096LP49
FPEEGHVDVKPDKRL	CCDC187	946	A0A096LP49
IGLRDVDPPEHFILK	ARG2	196	P78540
FGEKVVHHDPPLLFD	ARSL	501	P51690
PVEDVHPLSRAFFKL	ABCA10	1476	Q8WWZ4
EHADPLLKVSIIPRG	AFG3L2	586	Q9Y4W6
PEPLRIKLELDGDSH	ADAM15	66	Q13444
AIPSFKRDPFIGEHT	AMACR	336	Q9UHK6
EVIPGLDSKHPLTFR	AFAP1	396	Q8N556
GLVRFGVAPDHPEVK	FDXR	76	P22570
KDEAGVSEHPEAPAR	ARHGEF5	951	Q12774
AKALEPSFLPVAELH	GSE1	401	Q14687
PGKSVRAIVDVHFDP	AGRN	1196	O00468
RGPKVDVSAPDVEAH	AHNAK	606	Q09666
RVSSLLHKPEFPDGE	AMOTL1	936	Q8IY63
LGLRPFIPEKDSQHF	CCM2	351	Q9BSQ5
IPLEKADHPAVRAFL	CGGBP1	116	Q9UFW8
RTLPTPHSFKIGEEA	CCDC140	126	Q96MF4
GHKAELGERPEPVDF	ATP8B2	441	P98198
RDVFLVKEHPDPGSK	ASH2L	231	Q9UBL3
DRLHPGELADTPKSE	MTF2	301	Q9Y483
PETRGLKDPEHVEAL	NR2E3	331	Q9Y5X4
LEEQLPLGKASFHIP	PDCD1LG2	76	Q9BQ51
EKRLTPPEVSHGDRD	QSOX2	591	Q6ZRP7
LEKLHLFPSDAGVPL	HJV	391	Q6ZVN8
HAEFVPKADLLTLPG	FMN1	361	Q68DA7
DEAPEGKRLGFPVHT	FMN1	431	Q68DA7
AGPACPFLLHEEREK	FMN1	656	Q68DA7
PATEVDPTHFEKRFL	JAK1	861	P23458
ALDPVVRDSVPKEHI	HDHD3	216	Q9BSH5
PEDLDIPGHASKDRY	PTPN7	111	P35236
DKKERPTDEEGFLHP	ITPR3	1146	Q14573
KPHIIPFILDEIGAD	PYCR1	71	P32322
LRLPEREVTKEHGDP	KLF9	36	Q13886
VAKGSDEPPVFLEIH	LAP3	251	P28838
HVDEFLSFVPAPDRK	PADI4	471	Q9UM07
PSFEIPAKRHLGLVV	HDC	396	P19113
EPLLAKPARIVAGHE	TRAF3IP1	86	Q8TDR0
TIRAKPFHDSEELVP	IFT122	1041	Q9HBG6
RSIDHPGKLIFAPDL	ESR2	346	Q92731
VKAEAPLHDPDLDFL	KIAA1671	331	Q9BY89
PKTPEIFRALEGEAH	NCF2	231	P19878
LPDHFPEKGRLKREA	KCTD16	96	Q68DU8
PEKERPLVIGHFNTA	MFSD9	161	Q8NBP5
KPPADSGVDLREVEH	SLC16A3	431	O15427
KGDVFVAPRTDHPAL	TRMU	286	O75648
QLLRPGSLHKFIPEE	MTMR11	116	A4FU01
RLGHGDTVPLEEPKV	HERC2	526	O95714
KSLPSDFPRGHVEEL	DST	3461	Q03001
KDSGSIFLEVDPRHP	HEMK1	286	Q9Y5R4
PHVPDEKLGEAAVLE	SMPDL3B	96	Q92485
LKHVLARQPGPEAAE	CFAP58	761	Q5T655
HTSPDLKVRPELRGD	HPS5	561	Q9UPZ3
DKAGEARSPLEHSPI	KCNH5	876	Q8NCM2
IHTLGFPPTVRKIDA	MMP3	376	P08254
HLSKREFSPEPLEAI	BCL11A	11	Q9H165
PRKAVEFHEDLFPDT	CORO7	346	P57737
ETPPREGKSHFQILL	HSPB3	61	Q12988
ILFEEVHIPGSPFKA	FLNB	1111	O75369
GHLLPERKDFPVESV	PNN	521	Q9H307
EKVHTEGRSEPILLP	FOXO4	56	P98177
DRAAEPHFGTLPKAL	KSR1	416	Q8IVT5
TLEEKPAPTDVGLHR	PCDH9	736	Q9HC56
PDHTFLDEKGRCVPL	MUC2	701	Q02817
KDPKRSHFVLIAGEP	PIR	231	O00625
RDKLGPAAEIDHVIP	KALRN	1036	O60229
SKTFIIGELHPDDRP	CYB5A	76	P00167
RGSPFIKPFEHEIKA	DNAH12	876	Q6ZR08
KIPPHSLRVLEELEG	PI4KA	211	P42356
IDHTLPTPEAAEFLK	KDM4A	341	O75164
FEGPPLATRLLAHKI	GGA1	41	Q9UJY5
AAGKSPEDLERLLPH	GPI	451	P06744
PEDLERLLPHKVFEG	GPI	456	P06744
PFKGDVEHTIRDILG	GMPR2	296	Q9P2T1
GKFRPSDEHHPEVKA	LHPP	236	Q9H008
KLSVPDPEERLDSGH	FGD3	656	Q5JSP0
AEEKGVVLNRPFHPA	MON2	1001	Q7Z3U7
QPKPVVGHFSARELD	KIF18B	486	Q86Y91
VKPHDPATVDEVLRL	CRNN	46	Q9UBG3
EAGFEPVTRKPRIHE	FAM170B	126	A6NMN3
PRLQKPITGHLDDLF	NPHP4	231	O75161
PDVTRPEGKDFSIHR	RBBP4	51	Q09028
GDTKYEIHRDPTLDP	ALPI	291	P09923
KGHLLLDSDERPSPE	ABCC5	546	O15440
TKLPLIFHLGRDPGE	GALNS	436	P34059
PPSRRGSELHEIIDK	ERVK-19	256	Q9YNA8
KRPGDLPEVLSFHVD	GASK1A	321	Q9UFP1
LLDPFPDHVVFKDLR	ATM	1561	Q13315
EKSHDELPRTFQIPG	APOB	3236	P04114
QHPELTPLLEKERDG	IL32	111	P24001
PPDGLLRRKSDDVHL	KDM2B	786	Q8NHM5
RHKELFALHPSPDEE	DOCK7	231	Q96N67
LSVPDIPKEHFGQRL	DOCK7	251	Q96N67
EFRLLSKEGPAHEPK	ADAR	631	P55265
SPKREHLPLAVGIAF	EFNA3	216	P52797
IRKEGFFTVPPEHRL	CDK10	16	Q15131
TGEPLPKLDEVDRSH	DYTN	426	A2CJ06
VSHIEAAPFKAPELL	FRMPD2	76	Q68DX3
LLHDPPSEIAKDGRL	DIPK2A	381	Q8NDZ4
PEHLPLEVLEAGIKS	DIS3L	226	Q8TF46
LLELKHSNIGPFPVE	BPI	416	P17213
EKFPSEPNRLLLLHG	DPP8	816	Q6V1X1
GIIDPKESHRLPVDI	DSP	2376	P15924
LSRELKEPPQGAHFL	DHFR	76	P00374
RCDHLTLKEPFSGEP	GON4L	146	Q3T8J9
EPEEPKIRFVAGIHG	CPD	981	O75976
TGLIPVLEKEHDPRV	DHRS12	156	A0PJE2
GSPLELERLKLEPHE	SLC3A2	606	P08195
FDHSPIDGLEKLAPL	ANK3	3066	Q12955
PHIGDDPSIFITKII	DLG4	86	P78352
VLRDGVPPEASEHLK	LYST	456	Q99698
RDFPLVDGHNDLPLV	DPEP2	81	Q9H4A9
LSRELKEPPQGAHFL	DHFR2	76	Q86XF0
KEPPQGAHFLARSLD	DHFR2	81	Q86XF0
DYSDGDPLDVHKRLP	KCNMB3	36	Q9NPA1
DPLDVHKRLPSSAGE	KCNMB3	41	Q9NPA1
ARPGPVHFIDKVTDK	ARRDC1-AS1	36	Q9H2J1
HKFVAPEEVLPFTEG	EIF2B2	286	P49770
PAVHRLLGAPLKLED	FHOD1	56	Q9Y613
LEESLLDPFGAKPFH	BMP2KL	311	Q5H9B9
ALIVHGEKDPLVPRF	BPHL	236	Q86WA6
GEKDPLVPRFHADFI	BPHL	241	Q86WA6
FPKETFEGPKHEVLR	DHX40	606	Q8IX18
KIEREHQISPGDFPS	EHD1	341	Q9H4M9
IEAEKAIRGFSPPHR	PPP3CB	461	P16298
GTELPERTKPDFPDH	SAMD15	301	Q9P1V8
PKLPEGRFDAPEDSH	SDHAF4	51	Q5VUM1
GRFDAPEDSHLEKEP	SDHAF4	56	Q5VUM1
ARAISLGPHIPKTED	SLC38A11	141	Q08AI6
PRFLHLGPFKDTAVV	CDH9	356	Q9ULB4
HEDDHEGPELRKLPV	IPO13	656	O94829
QLKFLPRHSLPEDAG	CFAP74	866	Q9C0B2
HPEDPASVVEARKLE	DPP7	451	Q9UHL4
RAKPDLVITHPALDG	NLRP6	866	P59044
NLDKFEKGPREIFHP	GARNL3	171	Q5VVW2
IDDHFLFDKPVSPLL	CKMT1A	221	P12532
KELFVLPGEPRSQLH	LRP8	921	Q14114
VRPPHGFALFLAKEE	PKD1	3646	P98161
PCDKSPHFLRLGDVE	PTPRK	191	Q15262
HSVADPRHLPGEDVK	SLC12A5	26	Q9H2X9
LIDDHFLFDKPVSPL	CKMT2	221	P17540
LDIIRAALPPKDFAH	MTOR	456	P42345
AREAHSPGPLVKPFE	MSX2	86	P35548
IPERLSPEGKDFLSH	MAP3K4	1566	Q9Y6R4
SVFKGPLLHISPAEE	MOSPD2	321	Q8NHP6
IKDSPPEVAGARLHL	RARS2	541	Q5T160
EESEDHFPLLPRKPS	TSGA10IP	91	Q3SY00
FEKSVREDASPLPHV	TSEN2	206	Q8NCE0
HLPEPVAIKFLASDL	UTP20	2511	O75691
FPAEAFHKPGLEKEV	SUSD5	296	O60279
SRVAFDPEQKPLHGV	RRP1B	711	Q14684
HEETFGPLAPVIKFD	ALDH5A1	436	P51649
GVRFEDHEGLPTVVK	CARS1	626	P49589
PESPRFLLEVGKHDE	SV2C	341	Q496J9
RSPSFGPKHLEEEEE	SLITRK6	691	Q9H5Y7
LKNPIDSLPGELFHV	BMT2	226	Q1RMZ1
NPEGKPRLIFHRLED	NPHP3	386	Q7Z494
EKPAFGTPLEEHLKR	ARHGAP17	246	Q68EM7
PFKPEGELHELSTRL	NBEAL2	831	Q6ZNJ1
DFLPKTHLHGDEFLP	PPP1R32	241	Q7Z5V6
GRAELHPVELKPFQD	PRRC2A	2046	P48634
GAPPKDSTLLRDHEI	PPARGC1B	746	Q86YN6
RPKPLFHAVDEEGES	SLC9A4	746	Q6AI14
VPHLPEKQATGRFEE	SNX33	286	Q8WV41
DPAKHRILDPEGLAL	FTSJ3	656	Q8IY81
FGKEPLGPALAHELR	SELENBP1	446	Q13228
PIFTEHKTPFGLTRE	SPATA16	406	Q9BXB7
KPHIIPFILDEIGAD	PYCR2	71	Q96C36
GKHVPRALFVDLEPT	TUBAL3	66	A6NHL2
TVIRPLLHEFFDEKP	SI	1606	P14410
RPFGVPVSVDKDVHI	RNF220	46	Q5VTB9
FTDRGEHPLPARCKE	KIAA0753	321	Q2KHM9
LILPPEHILKRGDSE	ST7	426	Q9NRC1
TLHREFPAKEIPANG	PDGFRL	206	Q15198
GPEADAHRKPEAVVL	MLXIPL	151	Q9NP71
KELSPHLPALIRDSF	SKI	391	P12755
DPQLGPHADLFRKHE	SCMH1	606	Q96GD3
HRGDLITEPFLPKLL	SLC35A2	376	P78381
AERPLHFAEKVLPIL	ARAP1	1231	Q96P48
DLTLDLVLPRGPDHF	CHST5	391	Q9GZS9
GEKGERIHLTPDFIA	CLCA1	126	A8K7I4
GKHFIGDFLPPDELE	SUGP1	521	Q8IWZ8
SVDEIFKIERPGAHP	UHRF2	301	Q96PU4
FKIERPGAHPLSFAD	UHRF2	306	Q96PU4
VKKFLERSGPFTHPD	UBA3	41	Q8TBC4
FPEVLLTEIHLSPGK	VNN2	441	O95498
PEGVDPSRKEEHLSI	VIL1	781	P09327
KEHFPEGSRPVLSHL	UGT3A1	226	Q6NUS8
AHPLEPVLRGLKTAE	TTLL8	726	A6PVC2
PELVTGSKDHELDPR	TSC1	231	Q92574
KETLRLHPDIFLPSE	ZER1	31	Q7Z7L7
ADRVPISFKVLPGDH	TRAPPC11	46	Q7Z392
PVDGSVVRDFEHRPK	WDR88	131	Q6ZMY6
QGRHVEVFELLKPPS	MPDZ	131	O75970
HFVPLVTLKDSGPEI	TNFAIP3	256	P21580
HRLVPGPELEEKALV	SRCIN1	751	Q9C0H9
KAPTGPFKREELLDH	TMOD1	56	P28289
RLFPDESKRHGLPGV	RYR3	1641	Q15413
HPDLSPRGFQEIKEL	SYCE1	336	Q8N0S2
HREDGPGIPADIKLF	VPS35	311	Q96QK1
RLHHTGLPDFPAIKD	TOMT	266	Q8WZ04
VEPHKDPDATRFFGE	ZNF592	226	Q92610
KEEAESPERVLLPFH	THEMIS2	411	Q5TEJ8
GLEHPLFPKDIFHDL	SRGAP2	571	O75044
LLKTEIDADFPHPLR	POLK	491	Q9UBT6
PPFLLKEGRDDRLHS	UBE2O	461	Q9C0C9
LHKDRPVEPLDLAVF	UGT1A1	446	P22309
SLHKDRPVEPLDLAV	UGT1A5	446	P35504
PAFSLPKGEREVVTH	TROAP	256	Q12815
EEARPGDKEHVSPIA	MYCBPAP	626	Q8TBZ2
RDLPDDVLTFIKAHP	SEMA6C	386	Q9H3T2
DVLTFIKAHPLLDPA	SEMA6C	391	Q9H3T2
PPEHILKRGDSEAIA	ST7L	426	Q8TDW4
FAGGVKPFELHPRLE	TECPR2	261	O15040
ETPFHFTLPKEGDII	TP53BP1	901	Q12888
AGHFPIGPDVEDLVK	VCPIP1	966	Q96JH7
PFVKADLSIPDLHEI	RALGAPB	1036	Q86X10
RRPDKHFDPFTEGIV	PLCB1	656	Q9NQ66
FLEELHPKPSARDAP	ZNF469	1366	Q96JG9
LHFLSVVTEDGPEPK	ZNF232	186	Q9UNY5
AGPKAVAFIHTDLPE	ZDHHC8	686	Q9ULC8
EPQHELKFRGPFTDV	VAPB	11	O95292
FPVSKDDVPDRLHAE	PLEKHG1	861	Q9ULL1
RLEVEKAFHPFIAGP	HDLBP	226	Q00341
FGAVLRRPHDPKTVD	TCHH	41	Q07283
EPIHAVVLPRGKSLD	ZGPAT	361	Q8N5A5
AGAVEPHKAPALERL	TCIRG1	171	Q13488
LEPGRLAQHFPKTTE	TBK1	361	Q9UHD2
LHIKDDPDGIPSKRF	ZMIZ1	831	Q9ULJ6
ESADLLGDHRKVSPP	TMED8	141	Q6PL24
VRDVKPHSLDGLRPD	TM9SF1	181	O15321
EILGIEPDREKGFHL	TSN	121	Q15631
SLHKDRPVEPLDLAV	UGT1A4	446	P22310
SVLAEIRPKNDLGHP	AGL	941	P35573
KHPPATLEAIIREAE	KDM5C	996	P41229
FPEGDIRLCEKNIPH	LDAH	286	Q9H6V9
GLSEEEDPAPSRKIH	PPP1R9B	436	Q96SB3
KEPAVIGRPDFEHAV	NEBL	206	O76041
IGRPDFEHAVEASKL	NEBL	211	O76041